6 hrs ago | Medical News Today
Date Set For Stroke Survivors' Singing Group Concert
The 'Singing in the Rain' Aphasia Chorus are holding their first ever concert on 25 November in Cuckfield, West Sussex.
Merck Announces Completion Of Patient Enrollment In Phase III Trial...
Main Category: Cardiovascular / Cardiology Also Included In: Clinical Trials / Drug Trials ; Heart Disease Article Date: 17 Nov 2009 - 22:00 PST Merck announced the completion of patient enrollment in the TRA 2P-TIMI 50 clinical trial, a Phase III, randomized, double-blind, placebo-controlled, multinational study of SCH 530348, the company's ...
Pozen enrolling for Phase III study of heart drug
Pozen Inc. said Friday that it has begun enrolling 1,000 patients across the country for two Phase III studies for its experimental drug for use in the secondary prevention of heart attacks and strokes in patients at risk for associated gastric ulcers.
Study: Migraine Raises Risk of Stroke
Migraine headaches more than double the chances of the most common kind of stroke, which occurs when blood supply to the brain is suddenly cut off by a blood clot or plaque buildup.
FDA: Don't Use Plavix Along With Prilosec
The U.S. Food and Drug Administration is warning patients against using the stomach acid reducer Prilosec with the anti-clotting drug Plavix.
An aspirin a day: is it right for you? Some people may be able to take aspirin every day to lower heart attack or stroke risks.
Clopidogrel (marketed as Plavix) and Omeprazole (marketed as Prilosec) - Drug Interaction
FDA notified healthcare professionals of new safety information concerning an interaction between clopidogrel , an anti-clotting medication, and omeprazole , a proton pump inhibitor used to reduce stomach acid.
FDA: Anti-clotting drugs, PPIs may adversely affect each other
ROCKVILLE,A Md. Patients taking an anti-clotting drug should avoid the use of a drug for gastroesophageal reflux disease, the Food and Drug Administration warned Wednesday.
Newer Blood Thinners May Outperform Old Standbys
After years of little progress, three new trials suggest that the latest generation of blood thinners may outperform the old standbys warfarin and clopidogrel .
EDGEonthenet.com Health/Fitness Feed
Small firms scrapping, scaling back health plans
Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.
Investigational neurostimulation device aims to reduce stroke damage
Stroke researchers at the Methodist Neurological Institute in Houston are the only ones in Texas to offer a novel device that might extend the acute stroke treatment window from three hours to 24.
FDA warns that heartburn drug Prilosec can block benefits of blood thinner Plavix
Federal health officials said Tuesday a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.
Drug therapy more cost-effective than angioplasty for diabetic patients with heart disease
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD.
AstraZeneca Drug Tops Plavix in Sickest Patients
Heart attack patients in need of emergency procedures were less likely to suffer further serious cardiovascular events, including death, when given AstraZeneca's experimental Brilinta blood clot preventer than those who used Plavix, according to a study presented on Sunday.
Migraine headaches linked with increased risk of common kind of stroke
Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with more than twofold higher chances of the most common kind of stroke: those occurring when blood supply to the brain is suddenly cut off by the buildup of plaque or a blood clot.
New Mechanism Identified for Beneficial Effects of Aspirin in Cardiovascular Disease
On Sunday, November 15, 2009, Florida Atlantic University researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science will present at the American Heart Associationa s Annual Scientific Sessions meeting in Orlando, FL, the first data in humans to show that all doses of ...
Climbing stairs daily helps to lower the risk of suffering a stroke, according to the German Stroke Foundation.
American Heart Association Late-Breaking Clinical Trial Report: New...
Acutely ill heart attack patients who received both aspirin and a new reversible oral anti-platelet medication had fewer cardiac events than patients on aspirin and the most commonly used, irreversible anti-platelet drug, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions ...
Cynon Valley: Better service for stroke survivors
STROKE patients are receiving better and more efficient care from hospitals in Rhondda Cynon Taff.
Ending Aspirin Therapy may triple stroke risk
Thursday, November 12, 2009 When stroke survivors who are prescribed daily aspirin stop taking the drug, they may triple their risk of a having another stroke within days, research shows.
Also on Topix